HEXO Corp. (HEXO)
(Delayed Data from AMEX)
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $0.78 in the latest trading session, marking a -0.18% move from the prior day.
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $0.64, moving -1.08% from the previous trading session.
HEXO (HEXO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $0.76 in the latest trading session, marking a -0.91% move from the prior day.
Will HEXO (HEXO) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HEXO in Focus: Stock Moves 5.2% Higher
by Zacks Equity Research
HEXO saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
HEXO (HEXO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HEXO (HEXO) closed at $0.70, marking a +1.45% move from the previous day.
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HEXO (HEXO) closed at $0.69, marking a -1.39% move from the previous day.
Are Options Traders Betting on a Big Move in HEXO Stock?
by Zacks Equity Research
Investors need to pay close attention to HEXO stock based on the movements in the options market lately.
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis
Get Ready for a Green Rush in the Second Half: 3 Must Buys
by Tirthankar Chakraborty
With more states in the US and Canada likely to legalize marijuana and calls for marijuana decriminalization growing louder, the cannabis industry is poised to bounce back in the second half.
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba
by Zacks Equity Research
Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba
Is This a Buying Opportunity in the Marijuana Stocks?
by Tracey Ryniec
The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?
Do Options Traders Know Something About HEXO Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to HEXO stock based on the movements in the options market lately.
HEXO (HEXO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
HEXO (HEXO) delivered earnings and revenue surprises of 20.00% and 58.39%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Hexo Corp. (HEXO) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Hexo's (HEXO) fiscal third-quarter results are likely to reflect operational efficiency and strong product portfolio.
Analysts Estimate HEXO (HEXO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hexo, Brinks Company, Zoom Video and Crowdstrike highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Hexo, Brinks Company, Zoom Video and Crowdstrike highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Hexo Corp (HEXO)
by David Borun
There's a lot going for this low-priced cannabis company with a strong partnership
HEXO in Focus: Stock Moves 9% Higher
by Zacks Equity Research
HEXO saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Cannabis ETF Tops in May: 5 Stocks That Led The Way
by Sweta Killa
Inside the best performing stocks in the top cannabis ETF of May.
Do Options Traders Know Something About HEXO Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to HEXO stock based on the movements in the options market lately.
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions and Medical-Surgical Solutions segments.
Aurora Cannabis (ACB) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) fiscal third-quarter results likely to reflect solid prospects in the Canadian market.
What's in the Cards for SmileDirectClub's (SDC) Q1 Earnings?
by Zacks Equity Research
SmileDirectClub's (SDC) first-quarter performance is likely to reflect benefits from international presence and product development.